Tivity Health Sold to Stone Point Capital for $2 Billion

Client Type: Public Company

We represented Tivity Health Inc. (Nasdaq: TVTY), a leading provider of healthy life-changing solutions, in their sale to Stone Point Capital, an investment firm based in Greenwich, Connecticut, with over $40 billion of assets under management. Tivity Health stockholders received $32.50 in cash per share, representing a total transaction value of $2.0 billion. Tivity Health’s common stock ceased trading and will no longer be listed on Nasdaq.

The team was led by Bass, Berry & Sims attorneys Page Davidson, Tatjana Paterno and Scott Bell, and included corporate attorneys Tyler Huseman, Kolby Boyd, Chris Climo, Patton Webb and Emily Shiever. Bryan Metcalf advised on tax matters; Fritz Richter and Noah Black advised on employee benefits matters; Jim Tate and Vince Lillegard advised on debt matters; Luke Smith and Will Sohn advised on antitrust matters; and Shelley Thomas and Zane Cavender advised on intellectual property matters.

“For close to 35 years we’ve had the opportunity to represent Tivity Health. We are immensely grateful for our long standing partnership and look forward to supporting their continued growth and success,” said Page. To read the full press release announcing the agreement, click here.

The transaction was highlighted in several media outlets, including:

Tivity Health® Inc. (Nasdaq: TVTY) is a leading provider of healthy life-changing solutions, including SilverSneakers®, Prime® Fitness and WholeHealth Living®.

This transaction was named a winner in the M&A Deal of the Year (Between $1B-$5B) category at the 21st Annual M&A Advisor Awards hosted by The M&A Advisor.

In addition, the Tivity deal was named a finalist in the following categories for the 21st Annual M&A Advisor Awards in 2022:

  • Consumer Staples Deal of the Year (Over $100MM)
  • Healthcare/Life Sciences Deal of the Year (Over $500MM)
  • Corporate/Strategic Deal of the Year (Over $1B)
  • Private Equity Deal of the Year (Over $1B)
  • M&A Deal of the Year (Between $1B-$5B)

Bass, Berry & Sims was recognized as a finalist 15 times among several different categories representing six separate transactions for the 2022 Awards.

About the Bass, Berry & Sims Corporate & Securities Practice

Bass, Berry & Sims has significant experience representing buyers and sellers in both public and private company strategic transactions, as well as extensive familiarity in structuring private equity acquisitions and financings. We have served as counsel to national, major middle-market private equity funds and portfolio companies in more than 100 transactions across a myriad of industries in the last two years. Our work has earned the firm honors in national industry outlets, including being named Law Firm of the Year in 2021 by The M&A Advisor. We’ve consistently been recognized by The M&A Advisor for our deal work, most recently winning the Healthcare/Life Sciences Deal of the Year (Over $100MM) and M&A Deal of the Year ($50MM to $75MM) in 2021. In addition, the firm has been listed in leading league tables, including being ranked as #15 Most Active in U.S. Private Equity and #5 Most Active in Healthcare PE (PitchBook 2021). To learn more about our team, industry experience and value-add, click here.

We represented Tivity Health Inc. (Nasdaq: TVTY), a leading provider of healthy life-changing solutions, in their sale to Stone Point Capital, an investment firm based in Greenwich, Connecticut, with over $40 billion of assets under management. Tivity Health stockholders received $32.50 in cash per share, representing a total transaction value of $2.0 billion. Tivity Health’s common stock ceased trading and will no longer be listed on Nasdaq.

The team was led by Bass, Berry & Sims attorneys Page Davidson, Tatjana Paterno and Scott Bell, and included corporate attorneys Tyler Huseman, Kolby Boyd, Chris Climo, Patton Webb and Emily Shiever. Bryan Metcalf advised on tax matters; Fritz Richter and Noah Black advised on employee benefits matters; Jim Tate and Vince Lillegard advised on debt matters; Luke Smith and Will Sohn advised on antitrust matters; and Shelley Thomas and Zane Cavender advised on intellectual property matters.

“For close to 35 years we’ve had the opportunity to represent Tivity Health. We are immensely grateful for our long standing partnership and look forward to supporting their continued growth and success,” said Page. To read the full press release announcing the agreement, click here.

The transaction was highlighted in several media outlets, including:

Tivity Health® Inc. (Nasdaq: TVTY) is a leading provider of healthy life-changing solutions, including SilverSneakers®, Prime® Fitness and WholeHealth Living®.

This transaction was named a winner in the M&A Deal of the Year (Between $1B-$5B) category at the 21st Annual M&A Advisor Awards hosted by The M&A Advisor.

In addition, the Tivity deal was named a finalist in the following categories for the 21st Annual M&A Advisor Awards in 2022:

  • Consumer Staples Deal of the Year (Over $100MM)
  • Healthcare/Life Sciences Deal of the Year (Over $500MM)
  • Corporate/Strategic Deal of the Year (Over $1B)
  • Private Equity Deal of the Year (Over $1B)
  • M&A Deal of the Year (Between $1B-$5B)

Bass, Berry & Sims was recognized as a finalist 15 times among several different categories representing six separate transactions for the 2022 Awards.

About the Bass, Berry & Sims Corporate & Securities Practice

Bass, Berry & Sims has significant experience representing buyers and sellers in both public and private company strategic transactions, as well as extensive familiarity in structuring private equity acquisitions and financings. We have served as counsel to national, major middle-market private equity funds and portfolio companies in more than 100 transactions across a myriad of industries in the last two years. Our work has earned the firm honors in national industry outlets, including being named Law Firm of the Year in 2021 by The M&A Advisor. We’ve consistently been recognized by The M&A Advisor for our deal work, most recently winning the Healthcare/Life Sciences Deal of the Year (Over $100MM) and M&A Deal of the Year ($50MM to $75MM) in 2021. In addition, the firm has been listed in leading league tables, including being ranked as #15 Most Active in U.S. Private Equity and #5 Most Active in Healthcare PE (PitchBook 2021). To learn more about our team, industry experience and value-add, click here.